A carregar...
The Role of Biomarkers and Surrogate End Points in Drug Development for Neonatal Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a rare disease in newborns, infants, and children. It is associated with significant morbidity and mortality, but has limited treatment options. Except for inhaled nitric oxide, which is approved for persistent pulmonary hypertension of the newborn (PPHN), no...
Na minha lista:
| Publicado no: | Neoreviews |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5609821/ https://ncbi.nlm.nih.gov/pubmed/28943808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/neo.17-2-e87 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|